Sees FY25 revenue $2.19B-$2.22B, consensus $2.22B. Adjusted EBITDA is forecasted to be $405M-415M, which represents 60-70 basis points expansion year-over-year.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ENOV:
- ENOV Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Needham medtech & diagnostics analyst holds analyst/industry conference call
- Enovis Highlights Growth at J.P. Morgan Conference
- Closing Bell Movers: Cal-Maine Foods up 5% on Q2 results
- Maplebear to replace Enovis in S&P 400 at open on 1/14